Mediwelcome Healthcare Management & Technology (HKSE:02159) Stock Based Compensation: HK$0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02159 Mediwelcome Healthcare Management & Technology Inc HKSE:02159
56 GF Score
Price HK$1.72
GF Value HK$0.78
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Mediwelcome Healthcare Management & Technology Stock Based Compensation?

Mediwelcome Healthcare Management & Technology HKSE:02159 +1.18% 56 Stock Based Compensation is HK$0.0 Mil as of Jun. 2026. GuruFocus rates HKSE:02159 with a GF Score™ of 56/100 and a GF Value™ of HK$0.78 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Mediwelcome Healthcare Management & Technology's Stock Based Compensation for the six months ended in Jun. 2026 was HK$0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was HK$0.0 Mil.

Mediwelcome Healthcare Management & Technology Stock Based Compensation Related Terms

Mediwelcome Healthcare Management & Technology Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Mediwelcome Healthcare Management & Technology's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mediwelcome Healthcare Management & Technology Stock Based Compensation Chart

Mediwelcome Healthcare Management & Technology Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only 17.70 7.63 -0.77 0.00 0.00

Mediwelcome Healthcare Management & Technology Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:02159
56GF Score
Mediwelcome Healthcare Management & Technology Inc HKSE:02159
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mediwelcome Healthcare Management & Technology Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

What does a Stock Based Compensation of HK$0.0 Mil mean?
Mediwelcome Healthcare Management & Technology (HKSE:02159) has a Stock Based Compensation of HK$0.0 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Mediwelcome Healthcare Management & Technology and its competitors.
Is Mediwelcome Healthcare Management & Technology's Stock Based Compensation too high?
Mediwelcome Healthcare Management & Technology's current Stock Based Compensation is HK$0.0 Mil. Overall, Mediwelcome Healthcare Management & Technology has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mediwelcome Healthcare Management & Technology's Stock Based Compensation compare to VEEV and BTSG?
Mediwelcome Healthcare Management & Technology's Stock Based Compensation of HK$0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Mediwelcome Healthcare Management & Technology and its competitors. Mediwelcome Healthcare Management & Technology's current Stock Based Compensation is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediwelcome Healthcare Management & Technology stock overvalued right now?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology (HKSE:02159) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.78, compared to a current price of HK$1.72 — trading 120.5% above its estimated fair value. The current Stock Based Compensation is HK$0.0 Mil. Mediwelcome Healthcare Management & Technology's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Mediwelcome Healthcare Management & Technology (HKSE:02159), the current Stock Based Compensation is HK$0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mediwelcome Healthcare Management & Technology (HKSE:02159) Overvalued in 2026?

Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology stock appears to be overvalued. The current stock price of HK$1.72 is trading 120.5% above its estimated GF Value™ of HK$0.78. GuruFocus considers Mediwelcome Healthcare Management & Technology to be Significantly Overvalued.

Key valuation signals for HKSE:02159:

  • Stock Based Compensation: HK$0.0 Mil
  • GF Value™: HK$0.78 vs. price of HK$1.72 (120.5% above fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02159 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mediwelcome Healthcare Management & Technology Business Description

Address Wangjingdongyuan Zone 4, Wangjing East Park, 17th Floor, Block B, Greenland Center, Chaoyang District, Beijing, CHN, 100101
Mediwelcome Healthcare Management & Technology Inc is an investment holding company. The Group mainly provides medical conference services, patient education and screening services, and marketing and consulting services, in addition to providing integrated healthcare marketing solutions. Its products and services include Academic Conference Management System, Scientific Research Data Reporting System, the Health/Medical Media Matrix, patient management services, and marketing and consulting services. The Group has only one reportable segment, mainly operating its businesses in the PRC and earning revenue from the PRC.
56GF Score

Get the complete analysis for HKSE:02159

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.72
Price
HK$0.78
GF Value